SPONSOR
Hunan Cancer Hospital
Total Trials
4
Recruiting
4
Phases
Phase 2
Conditions studied: Breast NeoplasmsNeoplastic Cells, CirculatingChemotherapy EffectHR+ Breast CancerGastric CancerHepatocellular Carcinoma
Hunan Cancer Hospital is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Breast Neoplasms, Neoplastic Cells, Circulating, Chemotherapy Effect, HR+ Breast Cancer.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Hunan Cancer Hospital
How many clinical trials has Hunan Cancer Hospital sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Hunan Cancer Hospital, of which 4 are actively recruiting participants. These trials cover conditions including Breast Neoplasms, Neoplastic Cells, Circulating, Chemotherapy Effect. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Hunan Cancer Hospital research focus on?
Hunan Cancer Hospital clinical trials span Breast Neoplasms, Neoplastic Cells, Circulating, Chemotherapy Effect, HR+ Breast Cancer, Gastric Cancer, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Hunan Cancer Hospital clinical trial?
To participate in a Hunan Cancer Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Hunan Cancer Hospital trials with current recruitment status updated daily.
Clinical Trials by Hunan Cancer Hospital
NCT05326295
Recruiting
Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients
Breast Neoplasms
NCT06734533
Recruiting
Anlotinib-based Combination Therapy in Patients with Hormone Receptor-positive（HR+） Metastatic Breast Cancer(MBC) .
HR+ Breast Cancer
NCT06543108
Recruiting
Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PET/CT and PET/MR in Gastric Cancer
Gastric Cancer
NCT06406634 Phase 2
Recruiting
Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology